WARF: P06455US

  • Assigned to WARF as biological material.

Model for Stearoyl-CoA Desaturase Activity


James Ntambi, Makoto Miyazaki

The Wisconsin Alumni Research Foundation is seeking commercial partners interested in a transgenic mouse model for the human SCD5 isoform.
OVERVIEWStearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids. Inhibitors of SCD may be useful as therapeutic agents for the treatment of diseases such as obesity and diabetes. Various isoforms of SCD exist and are expressed at different developmental stages or in different tissues.
THE INVENTIONUW-Madison researchers have developed a transgenic mouse model for the human SCD5 isoform. This animal model is useful for screening the activity and substrate specificity of human SCD5, and for identifying compounds that may modulate SCD5.
  • Discovery of SCD inhibitors, particularly SCD 5 inhibitors
  • Development of potential therapeutics for obesity or diabetes 
  • Transgenic mice exhibit greater than a three-fold increase in SCD activity in their livers, making liver microsomes well suited for screening potential SCD inhibitors
For More Information About the Inventors
Contact Information
For current licensing status, please contact Rafael Diaz at or 608-960-9847.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.